Pentadecapeptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-09. Where a claim depends on a specific study, the study is described rather than over-claimed.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
| Property | Value | Notes |
|---|---|---|
| Amino acid count | 15 residues | Synthetic pentadecapeptide chain |
| Sequence | GEPPPGKPADDAGLV | Single-letter amino acid code |
| Molecular formula | C62H98N16O22 | Free peptide, without counter-ion |
| Theoretical mass | Approximately 1419.5 daltons | Varies slightly with adducts and counter-ions |
| Origin | Fragment of a human gastric juice protein | Source of the BPC designation |
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
=== Proteins === Proteins present in the hemolymph vary in quantity during the course of development. These proteins are classified by their functions: chroma proteins, protease inhibitors, storage, lipid transport, enzymes, the vitellogenins, and those involved in the immune responses of arthropods. Some hemolymphic proteins incorporate carbohydrates and lipids into the structure.
This reaction is exothermic and releases sufficient heat to ignite the resulting hydrogen in the presence of oxygen. Finely powdered potassium ignites in air at room temperature. The bulk metal ignites in air if heated. Because its density is 0.89 g/cm3, burning potassium floats in water that exposes it to atmospheric oxygen. Many common fire extinguishing agents, including water, either are ineffective or make a potassium fire worse. Nitrogen, argon, sodium chloride (table salt), sodium carbonate (soda ash), and silicon dioxide (sand) are effective if they are dry. Some Class D dry powder extinguishers designed for metal fires are also effective. These agents deprive the fire of oxygen and cool the potassium metal. During storage, potassium forms peroxides and superoxides. These peroxides may react violently with organic compounds such as oils. Both peroxides and superoxides may react explosively with metallic potassium. Because potassium reacts with water vapor in the air, it is usually stored under anhydrous mineral oil or kerosene. Unlike lithium and sodium, potassium should not be stored under oil for longer than six months, unless in an inert (oxygen-free) atmosphere, or under vacuum. After prolonged storage in air dangerous shock-sensitive peroxides can form on the metal and under the lid of the container, and can detonate upon opening. Ingestion of large amounts of potassium compounds, certain drugs, and homeostatic failure, can lead to hyperkalemia, leading to a variety of brady- and tachy-arrhythmias that can be fatal. Potassium chloride is used in the U.S.
== Expanded Tag/Catcher pairs == Before the development of SpyTag/SpyCatcher, the pair Isopeptag/Pilin-C was created from protein Spy0128 of Streptococcus pyogenes. Following SpyTag/SpyCatcher, the fully orthogonal pair SnoopTag/SnoopCatcher was developed from the RrgA protein of Streptococcus pneumoniae that has no cross-reactivity with SpyTag/SpyCatcher. Note that SnoopTag/SnoopCatcher forms an isopeptide bond between a Lys-Asn instead of Lys-Asp found in SpyTag/SpyCatcher. The same domain from RrgA has now been split in a different way to that used to create SnoopTag/SnoopCatcher, with the new pair called DogTag/DogCatcher. Unlike SpyTag and SnoopTag which have extended structures, the region of RrgA used to create DogTag forms a β-hairpin and so predisposed for successful insertion into protein loops. This ability has been successfully exploited to fluorescently label an internal loop of the mammalian TRPC5 membrane channel protein which cannot be modified at the protein termini, without impacting on the channel properties of TRPC5. DogTag has been successful coupled to DogCatcher when inserted into soluble proteins (superfolder GFP, HaloTag, and Gre2p). The pair SdyTag/SdyCatcher was also developed in the same year from Streptococcus dysgalactiae fibronectin-binding protein CnaB domain, but since the protein has sequence similarity to the parent protein where SpyTag/SpyCatcher is derived from, SdyTag/SdyCatcher has cross-reactivity with SpyTag/SpyCatcher.
== Signs and symptoms == Manifestations of hyperinsulinemic hypoglycemia vary by age and severity of the hypoglycemia. In general, most signs and symptoms can be attributed to (1) the effects on the brain of insufficient glucose (neuroglycopenia) or (2) to the adrenergic response of the autonomic nervous system to hypoglycemia. A few miscellaneous symptoms are harder to attribute to either of these causes. In most cases, all effects are reversed when normal glucose levels are restored. There are uncommon cases of more persistent harm, and rarely even death due to severe hypoglycemia of this type. One reason hypoglycemia due to excessive insulin can be more dangerous is that insulin lowers the available amounts of most alternate brain fuels, such as ketones. Brain damage of various types ranging from stroke-like focal effects to impaired memory and thinking can occur. Children who have prolonged or recurrent hyperinsulinemic hypoglycemia in infancy can suffer harm to their brains and may be developmentally delayed.
The articles of the 1790 diet set out that the diet should meet at least once every 3 years, but, since the diet was called by the Habsburg monarchy, this promise was not kept on several occasions thereafter. As a result of the Austro-Hungarian Compromise, it was reconstituted in 1867. The Latin term Natio Hungarica ("Hungarian nation") was used to designate the political elite which had participation in the diet, consisting of the nobility, the Catholic clergy, and a few enfranchised burghers, regardless of language or ethnicity. Today's parliament is still called the Országgyűlés, as in royal times, but is called the 'National Assembly' to distance itself from the historical royal diet. Under communist rule, the National Assembly was defined as the "supreme body of state power" (after 1972: "supreme body of state power and popular representation"). Per the principle of unified power, it was the sole branch of government in Hungary, and all state organs were subordinated to it. Under the Constitution of 1949, initially drafted by the communists, it was vested with great lawmaking and oversight powers. In practice, as with most other communist legislatures, it did little more than ratify decisions already made by the Communist Hungarian Socialist Workers' Party and its Politburo. The Assembly only sat twice a year. The Presidential Council exercised most of the Assembly's powers between sessions, but could not amend the Constitution. The Presidential Council could also issue edicts in lieu of law.
Sources: en.wikipedia.org
Moreover, both the refractive index and the optical absorption are found to be dispersionless over a broad wavelength range from visible to near infrared. Finally, GO film offers flexible patterning capability by using the maskless DLW method, which reduces the manufacturing complexity and requirements. As a result, a novel ultrathin planar lens on a GO thin film has been realized recently using the DLW method. The distinct advantage of the GO flat lens is that phase modulation and amplitude modulation can be achieved simultaneously, which are attributed to the giant refractive index modulation and the variable linear optical absorption of GO during its reduction process, respectively. Due to the enhanced wavefront shaping capability, the lens thickness is pushed down to subwavelength scale (~200 nm), which is thinner than all current dielectric lenses (~ μm scale). The focusing intensities and the focal length can be controlled effectively by varying the laser powers and the lens sizes, respectively. By using an oil immersion high numerical aperture (NA) objective during DLW process, 300 nm fabrication feature size on GO film has been realized, and therefore the minimum lens size has been shrunk down to 4.6 μm in diameter, which is the smallest planar micro lens and can only be realized with metasurface by FIB. Thereafter, the focal length can be reduced to as small as 0.8 μm, which would potentially increase the numerical aperture (NA) and the focusing resolution.
===== "Treasure Cave B" (Cave 84, 300–350 CE) ===== Cave 84 (Treasure Cave B) was a square, probably domed cave (4x4m, here too the ceiling has collapsed), exemplifying an earlier, simpler cave structure at Kizil, which is also known from Bamiyan (Cave 24). The origin of the paintings in caves 84 seems Indian, probably from Kashmir. They show groups of people standing around figures of the Buddha, who is either seated or standing. The depth of placement is rather shallow, the figures are graceful with curved torsos. The faces are round and plump. Rhies suggest a date of the first half of the 4th century for Cave 84. All the paintings were sent to Berlin by Grünwedel. These two caves are adjoined to cave 82, an undecorated vihara also dated to 300–350 CE, and cave 85, a small ruined cave.
==== Disney California Adventure ==== By San Diego Comic-Con 2016, the Tower of Terror at Disney California Adventure was set to be replaced by a new attraction, Guardians of the Galaxy – Mission: Breakout!. Chris Pratt, Zoë Saldaña, Dave Bautista and Benicio del Toro all filmed exclusive footage for the attraction, reprising their roles as Peter Quill / Star-Lord, Gamora, Drax and Taneleer Tivan / The Collector, respectively. James Gunn, director of Guardians of the Galaxy and its sequel, directed footage for the attraction and consulted on all aspects of it. Guardians of the Galaxy – Mission: Breakout! sees visitors assisting Rocket in rescuing the other Guardians from the Collector's fortress, while the attraction features randomized events throughout the experience and music inspired by the Awesome Mix Vol. 1 soundtrack. The attraction opened on May 27, 2017. In March 2018, the Walt Disney Company announced a new Marvel-themed area inspired by the MCU at Disney California Adventure, anchored by Mission: Breakout!, that features characters from the MCU, such as Iron Man and Spider-Man, joining the Guardians of the Galaxy in a "completely immersive superhero universe". The area replaced "A Bug's Land", which closed in mid-2018 to begin construction of the Marvel area. Tom Holland reprises his role as Peter Parker / Spider-Man in the attraction Web Slingers: A Spider-Man Adventure, in which Parker has set up W.E.B. (the Worldwide Engineers Brigade) to inspire a new generation to use technology to save the world.
All nuclear data not otherwise stated is from the standard source: Twenty isotopes of californium are known with mass number ranging from 237 to 256; the most stable are 251Cf with half-life 898 years, 249Cf with half-life 351 years, 250Cf at 13.08 years, and 252Cf at 2.645 years. All other isotopes have half-life shorter than a year, and most of these have half-lives less than 20 minutes. 249Cf is formed by beta decay of berkelium-249, and heavier californium isotopes are made by subjecting berkelium to intense neutron radiation in a nuclear reactor. Though californium-251 has the longest half-life, its production yield is relatively low due to its rapid depletion by reaction with another neutron (high neutron cross section). 252Cf is a very strong neutron emitter, which makes it an extremely hazardous radioactive isotope. 252Cf, 96.9% of the time, alpha decays to curium-248; the other 3.1% of decays are spontaneous fission. One microgram of 252Cf emits 2.3 million neutrons per second (about 3.7 neutrons per fission). The other main isotopes of californium (248-251) also alpha decay to those of curium, with a much smaller fraction of fission.
Sources: en.wikipedia.org
The peptide is synthetic, but its sequence matches a segment of a protein present in human gastric juice. It does not occur as a free fifteen-residue peptide in the body.
Rodents account for the large majority of published experiments. Human data are sparse and mostly observational, so cross-species extrapolation remains uncertain.
It is not an approved therapeutic in most jurisdictions. Regulatory status varies by country, and several places restrict it as a research chemical.
The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.